申请人:Rhone-Poulenc Sante
公开号:US04783472A1
公开(公告)日:1988-11-08
A compound of the general formula I; ##STR1## in which R is hydrogen or a halogen or an alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino, benzamido, phenyl, phenoxy or phenylthio group, X is oxygen or sulphur or an imino, alkylimino, phenylimino, benzylimino, sulphinyl, sulphonyl, carbonyl, carbonylmethylene, methylenecarbonyl, carbonylvinylene or vinylenecarbonyl group, or X represents a valency bond or a straight-chain alkylene group containing 1 to 4 carbon atoms and Ar is a phenyl, naphthyl, pyridyl, quinolinyl, isoquinolinyl, thienyl, benzothienyl, thieno[3,2-b]thien-2-yl or thieno[2,3-b]thien-2-yl group, it being possible for the group Ar to be unsubstituted or substituted with one or more halogen or alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino or benzamido group; each alkyl moiety containing 1 to 4 straight- or branched-chain carbon atoms; the compound being in separate enantiomeric form or mixtures thereof or a pharmaceutically acceptable salt thereof is useful in the treatment of all the pathological conditions in which PAF-acether may be directly or indirectly implicated.
通式I的化合物; 在其中R是氢或卤素或烷基,烷氧基,烷硫基,三氟甲基,氨基,烷基氨基,二烷基氨基,羟基,氰基,羧基,烷基磺氧基,烷基磺酰基,磺胺基,烷基磺胺基,二烷基磺胺基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,苯基氨基甲酰基,二苯基氨基甲酰基,吡啶基氨基甲酰基,二吡啶基氨基甲酰基,苄基,烷基羰基,苯甲酰基,烷氧羰基,苯氧羰基,烷基羰氧基,苯甲氧基,烷基羰基氨基,苯甲酰胺,苯基,苯氧基或苯硫基,X是氧或硫或亚胺,烷基亚胺,苯基亚胺,苄基亚胺,磺氧基,磺酰基,羰基,羰基亚甲基,亚甲基羰基,羰基乙烯基或乙烯基羰基,或X代表价键或含有1至4个碳原子的直链烷基基团,Ar是苯基,萘基,吡啶基,喹啉基,异喹啉基,噻吩基,苯并噻吩基,噻吩[3,2-b]噻-2-基或噻吩[2,3-b]噻-2-基,其中Ar基可能未取代或取代有一个或多个卤素或烷基,烷氧基,烷硫基,三氟甲基,氨基,烷基氨基,二烷基氨基,羟基,氰基,羧基,烷基磺氧基,烷基磺酰基,磺胺基,烷基磺胺基,二烷基磺胺基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,苯基氨基甲酰基,二苯基氨基甲酰基,吡啶基氨基甲酰基,二吡啶基氨基甲酰基,苄基,烷基羰基,苯甲酰基,烷氧羰基,苯氧羰基,烷基羰氧基,苯甲氧基,烷基羰基氨基,苯甲酰胺或苯基群; 每个烷基基团含有1至4个直链或支链碳原子; 该化合物以单独的对映体形式或其混合物或其药学上可接受的盐形式在PAF-乙酯可能直接或间接涉及的所有病理条件的治疗中是有用的。